These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34975167)

  • 1. Antimicrobial resistance in bovine respiratory disease: Auction market- and ranch-raised calves.
    Wennekamp TR; Waldner CL; Windeyer MC; Larson K; Trokhymchuk A; Campbell JR
    Can Vet J; 2022 Jan; 63(1):47-54. PubMed ID: 34975167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and antimicrobial susceptibility of Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni isolated from the lower respiratory tract of healthy feedlot cattle and those diagnosed with bovine respiratory disease.
    Timsit E; Hallewell J; Booker C; Tison N; Amat S; Alexander TW
    Vet Microbiol; 2017 Sep; 208():118-125. PubMed ID: 28888626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and temporal trends in antimicrobial resistance of bovine respiratory disease pathogen isolates submitted to the Wisconsin Veterinary Diagnostic Laboratory: 2008-2017.
    Holschbach CL; Aulik N; Poulsen K; Ollivett TL
    J Dairy Sci; 2020 Oct; 103(10):9464-9472. PubMed ID: 32747101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment history and antimicrobial susceptibility results for Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni isolates from bovine respiratory disease cases submitted to the Iowa State University Veterinary Diagnostic Laboratory from 2013 to 2015.
    Magstadt DR; Schuler AM; Coetzee JF; Krull AC; O'Connor AM; Cooper VL; Engelken TJ
    J Vet Diagn Invest; 2018 Jan; 30(1):99-104. PubMed ID: 29034785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A ten-year (2000-2009) study of antimicrobial susceptibility of bacteria that cause bovine respiratory disease complex--Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni--in the United States and Canada.
    Portis E; Lindeman C; Johansen L; Stoltman G
    J Vet Diagn Invest; 2012 Sep; 24(5):932-44. PubMed ID: 22914822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic relatedness and antimicrobial resistance in respiratory bacteria from beef calves sampled from spring processing to 40 days after feedlot entry.
    Guo Y; McMullen C; Timsit E; Hallewell J; Orsel K; van der Meer F; Yan S; Alexander TW
    Vet Microbiol; 2020 Jan; 240():108478. PubMed ID: 31902491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limitations of bacterial culture, viral PCR, and tulathromycin susceptibility from upper respiratory tract samples in predicting clinical outcome of tulathromycin control or treatment of bovine respiratory disease in high-risk feeder heifers.
    Sarchet JJ; Pollreisz JP; Bechtol DT; Blanding MR; Saltman RL; Taube PC
    PLoS One; 2022; 17(2):e0247213. PubMed ID: 35143504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between antimicrobial drug class for treatment and retreatment of bovine respiratory disease (BRD) and frequency of resistant BRD pathogen isolation from veterinary diagnostic laboratory samples.
    Coetzee JF; Magstadt DR; Sidhu PK; Follett L; Schuler AM; Krull AC; Cooper VL; Engelken TJ; Kleinhenz MD; O'Connor AM
    PLoS One; 2019; 14(12):e0219104. PubMed ID: 31835273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agreement of antimicrobial susceptibility testing of Pasteurella multocida and Mannheimia haemolytica isolates from preweaned dairy calves with bovine respiratory disease.
    Credille BC; Capik SF; Credille A; Crossley BM; Blanchard P; Woolums AR; Lehenbauer TW
    Am J Vet Res; 2023 Nov; 84(11):. PubMed ID: 37558231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of in vitro minimum inhibitory concentrations of tilmicosin against Mannheimia haemolytica and Pasteurella multocida and in vivo tilmicosin treatment outcome among calves with signs of bovine respiratory disease.
    McClary DG; Loneragan GH; Shryock TR; Carter BL; Guthrie CA; Corbin MJ; Mechor GD
    J Am Vet Med Assoc; 2011 Jul; 239(1):129-35. PubMed ID: 21718206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy of enrofloxacin to that of tulathromycin for the control of bovine respiratory disease and prevalence of antimicrobial resistance in Mannheimia haemolytica in calves at high risk of developing bovine respiratory disease.
    Crosby S; Credille B; Giguère S; Berghaus R
    J Anim Sci; 2018 Apr; 96(4):1259-1267. PubMed ID: 29471391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A literature review of antimicrobial resistance in Pathogens associated with bovine respiratory disease.
    DeDonder KD; Apley MD
    Anim Health Res Rev; 2015 Dec; 16(2):125-34. PubMed ID: 26373635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activities of tulathromycin and ceftiofur combined with other antimicrobial agents using bovine Pasteurella multocida and Mannheimia haemolytica isolates.
    Sweeney MT; Brumbaugh GW; Watts JL
    Vet Ther; 2008; 9(3):212-22. PubMed ID: 19003782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New interpretive criteria for danofloxacin antibacterial susceptibility testing against Mannheimia haemolytica and Pasteurella multocida associated with bovine respiratory disease.
    Sweeney MT; Papich MG; Watts JL
    J Vet Diagn Invest; 2017 Mar; 29(2):224-227. PubMed ID: 28064562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of standardised versus non-standardised methods for testing the in vitro potency of oxytetracycline against Mannheimia haemolytica and Pasteurella multocida.
    Lees P; Illambas J; Pelligand L; Toutain PL
    Vet J; 2016 Dec; 218():60-64. PubMed ID: 27938710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mannheimia haemolytica and Pasteurella multocida in Bovine Respiratory Disease: How Are They Changing in Response to Efforts to Control Them?
    Snyder E; Credille B
    Vet Clin North Am Food Anim Pract; 2020 Jul; 36(2):253-268. PubMed ID: 32327253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence-based effectiveness of vaccination against Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni in feedlot cattle for mitigating the incidence and effect of bovine respiratory disease complex.
    Larson RL; Step DL
    Vet Clin North Am Food Anim Pract; 2012 Mar; 28(1):97-106, 106e1-7, ix. PubMed ID: 22374120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and antimicrobial susceptibilities of bacterial pathogens from bovine pneumonia: 1994--2002.
    Welsh RD; Dye LB; Payton ME; Confer AW
    J Vet Diagn Invest; 2004 Sep; 16(5):426-31. PubMed ID: 15460326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and Risk Factors Associated With Antimicrobial Resistance in Bacteria Related to Bovine Respiratory Disease-A Broad Cross-Sectional Study of Beef Cattle at Entry Into Canadian Feedlots.
    Andrés-Lasheras S; Ha R; Zaheer R; Lee C; Booker CW; Dorin C; Van Donkersgoed J; Deardon R; Gow S; Hannon SJ; Hendrick S; Anholt M; McAllister TA
    Front Vet Sci; 2021; 8():692646. PubMed ID: 34277758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Observations on macrolide resistance and susceptibility testing performance in field isolates collected from clinical bovine respiratory disease cases.
    DeDonder KD; Harhay DM; Apley MD; Lubbers BV; Clawson ML; Schuller G; Harhay GP; White BJ; Larson RL; Capik SF; Riviere JE; Kalbfleisch T; Tessman RK
    Vet Microbiol; 2016 Aug; 192():186-193. PubMed ID: 27527782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.